Literature DB >> 26721412

Introduction: drug discovery and development for neglected diseases.

Louise S Goupil1,2, James H McKerrow1,2.   

Abstract

Mesh：

Year:  2014        PMID： 26721412     DOI： 10.1021/cr500546h

Source DB:  PubMed          Journal:  Chem Rev        ISSN： 0009-2665            Impact factor:   60.622


× No keyword cloud information.
  9 in total

1.  Assembling Pharma Resources to Tackle Diseases of Underserved Populations.

Authors:  Dale J Kempf; Kennan C Marsh
Journal:  ACS Med Chem Lett       Date:  2020-03-27       Impact factor: 4.345

2.  Bioactive compounds of Aspergillus terreus-F7, an endophytic fungus from Hyptis suaveolens (L.) Poit.

Authors:  Igor Pereira da Silva; Elson Brissow; Luis Claudio Kellner Filho; Jaqueline Senabio; Kátia Aparecida de Siqueira; Samuel Vandresen Filho; Jaqueline Lopes Damasceno; Suzana Amorim Mendes; Denise Crispim Tavares; Lizandra Guidi Magalhães; Policarpo Ademar Sales Junior; Ana Helena Januário; Marcos Antônio Soares
Journal:  World J Microbiol Biotechnol       Date:  2017-02-27       Impact factor: 3.312

3.  Enterocin AS-48 as Evidence for the Use of Bacteriocins as New Leishmanicidal Agents.

Authors:  María Ángeles Abengózar; Rubén Cebrián; José María Saugar; Teresa Gárate; Eva Valdivia; Manuel Martínez-Bueno; Mercedes Maqueda; Luis Rivas
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

4.  Multicomponent reaction-based synthesis and biological evaluation of tricyclic heterofused quinolines with multi-trypanosomatid activity.

Authors:  Ornella Di Pietro; Esther Vicente-García; Martin C Taylor; Diana Berenguer; Elisabet Viayna; Anna Lanzoni; Irene Sola; Helena Sayago; Cristina Riera; Roser Fisa; M Victòria Clos; Belén Pérez; John M Kelly; Rodolfo Lavilla; Diego Muñoz-Torrero
Journal:  Eur J Med Chem       Date:  2015-10-19       Impact factor: 6.514

5.  Relevance of Trypanothione Reductase Inhibitors on Trypanosoma cruzi Infection: A Systematic Review, Meta-Analysis, and In Silico Integrated Approach.

Authors:  Andréa Aparecida Santos Mendonça; Camila Morais Coelho; Marcia Paranho Veloso; Ivo Santana Caldas; Reggiani Vilela Gonçalves; Antônio Lucio Teixeira; Aline Silva de Miranda; Rômulo Dias Novaes
Journal:  Oxid Med Cell Longev       Date:  2018-10-24       Impact factor: 6.543

6.  Paenidigyamycin A, Potent Antiparasitic Imidazole Alkaloid from the Ghanaian Paenibacillus sp. DE2SH.

Authors:  Enoch Osei; Samuel Kwain; Gilbert Tetevi Mawuli; Abraham Kwabena Anang; Kofi Baffour-Awuah Owusu; Mustafa Camas; Anil Sazak Camas; Mitsuko Ohashi; Cristina-Nicoleta Alexandru-Crivac; Hai Deng; Marcel Jaspars; Kwaku Kyeremeh
Journal:  Mar Drugs       Date:  2018-12-24       Impact factor: 5.118

Review 7.  Challenges in drug discovery targeting TriTryp diseases with an emphasis on leishmaniasis.

Authors:  Laura M Alcântara; Thalita C S Ferreira; Fernanda R Gadelha; Danilo C Miguel
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2018-09-28       Impact factor: 4.077

Review 8.  Screening Marine Natural Products for New Drug Leads against Trypanosomatids and Malaria.

Authors:  María Álvarez-Bardón; Yolanda Pérez-Pertejo; César Ordóñez; Daniel Sepúlveda-Crespo; Nestor M Carballeira; Babu L Tekwani; Sankaranarayanan Murugesan; Maria Martinez-Valladares; Carlos García-Estrada; Rosa M Reguera; Rafael Balaña-Fouce
Journal:  Mar Drugs       Date:  2020-03-31       Impact factor: 5.118

9.  Synthesis of bicyclic 1,4-thiazepines as novel anti-Trypanosoma brucei brucei agents.

Authors:  Franco Vairoletti; Andrea Medeiros; Pablo Fontán; Jennifer Meléndrez; Carlos Tabárez; Gustavo Salinas; Jaime Franco; Marcelo A Comini; Jenny Saldaña; Vojtech Jancik; Graciela Mahler; Cecilia Saiz
Journal:  Medchemcomm       Date:  2019-06-11       Impact factor: 3.597
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.